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Interactions between cellular components of the immune system are medi- 
ated,  at  least  in  part,  by macromolecular  chemical  signals  or  lymphokines. 
This is true both for cellular immunity (cf. 1, 2 for reviews), and for the hu- 
moral immune response (cf. 3, 4 for reviews). The first indication of the latter 
was  described by Hartmann  in  1970  (5),  who reported  enhancement of the 
number of plaque-forming cells (PFC)  against  sheep erythrocytes (SRBC)  in 
vitro when T  cells from animals  primed with horse erythrocytes were added 
with  horse  erythrocytes and  SRBC  to  normal  spleen  cell  cultures.  In  1971, 
Dutton et al.  (6)  reported that the supernatant fluid from mixed  lymphocyte 
cultures of allogeneic mouse cells restored the plaque-forming cell responses  of 
mouse spleen cultures depleted of T  cells by antiserum. At the same time Rubin 
and  Coons  (7)  confirmed  and  extended  Hartmann's  findings  using  tetanus 
toxoid and other antigens for "nonspecific" enhancement. Such enhancement is 
due to a factor released by sensitized lymphocytes upon renewed contact with 
antigen.  Subsequent reports have confirmed and extended these findings  (8). 
The enhancing factor (EF) liberated from primed mouse spleen or thymus cells 
by antigen or allogeneic stimulation had a  mol wt,  in our hands,  of approxi- 
mately 75,000  daltons as measured by gel filtration on both dextran and poly- 
acrylamide bead columns (8). 
In this paper, we report the isolation of a  soluble mediator from allogeneic 
mixtures of human lymphocyte cell lines which can nonspecifically enhance the 
humoral immune response of mouse spleen cells. This human enhancing factor 
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(HEF)  eluted from columns of Sephadex G-150 and BioGel P-150, with mole- 
cules of approximately 35,000 daltons. 
Materials and Methods 
Supernates were prepared from cultures of allogeneic mixtures of normal human lympho- 
cyte cell lines. Cell lines RPMI 1788 (HL-A2, 7) and RPMI 4098 (I-IL-A3) (Associated Bio- 
medic Systems, Inc., Buffalo, N. Y.) were maintained in medium RPMI 1640 supplemented 
with 10% fetal calf serum.  Equal volumes of each cell line containing 2.5-5.0  X  10 ~ viable 
cells/ml were mixed and cultured in spinner flasks for 24 h. The supernatant fluid was har- 
vested by centrifngation (200 g,  10 min, 4°C) and stored at --20°C until fracfionated and 
assayed for enhancing activity. Allogeneic supernatants were fractionated by gel filtration on 
Sephadex G-150 (Pharmacia Fine Chemicals, Piscataway, N. J.) and BioGel P-150 (Bio-Rad 
Laboratories, Richmond,  Calif.)  on an 87  X  1.1-cm glass column  by methods previously 
described  (8). 
Molecular weight calibration curves for the Sephadex and BioGel columns were produced 
by gel filtration of chemical  markers of known  molecular  weight  as described  earlier (8). 
Supernates were fracfionated and the column aliquots assayed for their ability nonspecificaily 
to increase  the anfi-SRBC PFC response of normal mouse spleen cell cultures,  i.e. for the 
presence of HEF, by methods used in previous reports (7, 8). Briefly, spleen cell cultures from 
normal 2-4-mo old DBA/2 female mice  (Jackson  Laboratories, Bar Harbor, Maine)  were 
prepared by a modification of the method of Mishell and Dutton (7, 9) and were stimulated 
with 3 million SRBC  on  day 0.  Filtered column  fractions,  diluted in fresh  medium,  were 
added to such cultures on day 2. Direct "19S" plaques against SRBC  were enumerated on 
day 5. The degree of enhancement  is expressed as the percent difference between the numbers 
of plaques produced in cultures that received diluted column fractions compared to the PFC 
response of similar cultures that received only the diluent. HEF was concentrated and purified 
from the allogeneic supernates by ammonium  sulfate  fractionafion followed by gel filtration 
on Sephadex G-150, and polyacrylamide  gel electrophoresis  (8). 
RESULTS 
The results of a  representative Sephadex G-150 gel filtration experiment are 
shown  in Fig.  1.  The column was calibrated with a  mixture of four chemical 
markers of known molecular weight which were fractionated into four separate 
symmetrical peaks  of  activity (8).  The  elution  pattern  of  these  markers  on 
Sephadex G-150 is indicated in Fig. 1 by the position of their respective molecu- 
lar weights  (arrows). When  a  2.0-ml sample of a  24-h  allogeneic supernatant 
was applied to the standardized G-150 column, we obtained two peaks of ab- 
sorbance at 280 nm.  Peaks of absorbance, due to the presence of fetal bovine 
serum components  in the culture medium, were found at fractions 13  (28.6 ml 
of eluant) and 18 (39.6 ml of eluant), respectively (Fig. 1). Successive column 
fractions were  assayed for  the presence  of the nonspecific human  enhancing 
factor by addition of diluted aliquots to cultures of SRBC-stimulated, normal 
mouse  spleen  cells. As shown  in Fig.  1,  when  column fractions  were  diluted 
1 : 200 with complete medium and added to test cultures, a symmetrical peak of 
enhancing  activity was found between fractions 19 and  25  (41.8  and 55.0 ml 
of eluant,  respectively) with  a  peak  of activity after fraction 22  (48.4  ml of 
eluant). Higher or lower dilutions of the peak fractions produced less enhance- RUBIN  ET  AL.  BRIEF  DEFINITIVE  REPORT  441 
o  o  o  o  o 
~O  .  O  CO 
0,5  I00 
g  0.4  8o  ~ 
0.3  60  ~,,o 
o  0.2  40  ~ 
I 
o.I  Is  20  ~.~ 
o_ 
0.0  __=-J__-:=_-J-J  --J-  0 
,  r-~5  o  ,o  r, 
ELUTION  VOLUME (ML) 
FIG. 1.  Sephadex G-150 fractionation of the 24-h supernate from human lymphocyte cell 
fines. (O--Q), absorbance at 280 nm; (O---C)), percent enhancement of PFC response (at 
1:200 dilution) by an aUogeneic supernate from a mixed culture of cell lines RPMI 1788 and 
4098; (I-"-m), percent enhancement of PFC response (at 1:200 dilution) by the supernate of 
cell line RPMI 1788. 
ment than the  optimal dilution. This peak of activity was consistently found 
to elute with molecules with a  tool wt of approximately 35,000  daltons. This 
was confirmed by gel filtration on a  column of BioGel P-150.  An  enhancing 
molecule of similar size has also been isolated from the supernate of cultures of 
freshly  drawn,  normal  human  peripheral  blood  leukocytes  cultured  in  the 
presence of tetanus toxoid. 1 The leukocyte donor was shown to be primed to 
the toxoid antigen by finding antitoxin in his serum. 
In contrast to the activity found in the supernatant fluid of cultures of mixed 
human lymphocytes, the culture medium from either cell line alone was devoid 
of detectable enhancing activity. (See Fig. 1). 
The HEF from 100 ml of allogeneic supernatant was purified by a combina- 
tion of preparative and analytical techniques  (8). HEF-rich culture fluid was 
first treated with 50 % ammonium sulfate. The enhancing activity in the 50 % 
supernate was then precipitated by increasing the concentration of ammonium 
sulfate to 70 %. The precipitate was redissolved in 5 ml of phosphate buffered 
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saline  (PBS) and a  2.5-ml sample was fractionated on a  column of Sephadex 
G-150. A single peak of enhancing activity was found to elute with molecules 
of 35,000 daltons. The three successive fractions embracing this peak from each 
of two column runs were pooled and concentrated to  1 ml by pervaporation. 
25-150-/zl  samples were then subjected to disc electrophoresis on a step-gradient 
polyacrylamide gel  containing 4.5,  6.0,  and  8.0%  acrylamide in  Tris-sulfate 
buffer, pH 9.0  (8). The pattern of migration (150-/zl sample) on a  gel stained 
with amido black is shown in Fig. 2. An unstained gel, run in parallel, was cut 
FIo. 2.  Polyacrylamide gel electrophoresis of an HEF-rich, 24-h supernatant from a mixed 
culture of cell lines RPMI  1788 and 4098.  The culture supernate was fractionated with am- 
monium sulfate, followed by Sephadex G-150 gel filtration. A  150-/zl sample of a concentrated 
pool of the peak Sephadex fractions was subjected to electrophoresis. The gel was fixed and 
stained with 0.17% amido black in 10% acetic acid. Dashed lines indicate sectioning of an 
unstained gel  run in parallel.  Arrow points  to faint band.  HEF  activity was  confined  to 
section B. 
into four sections as indicated (Fig. 2). The sections were homogenized in cold 
PBS,  centrifuged to  remove acrylamide, then dialyzed to remove toxic com- 
ponents (8). Enhancing activity was restricted to section B, which contained 
one faint band (arrow). The HEF recovered from this section was able to aug- 
ment the PFC response of assay cultures by an average of 75 % at a 1 : 200 dilu- 
tion of the B supernatant. 
DISCUSSION 
Intensive study of long-term lymphoblastoid cell lines, derived from human 
peripheral blood, has shown that these cells can synthesize a variety of products 
including some mediators of  cellular immunity (lO).  In  this report, we have RUBIN  ET  AL.  BRIEF  DEFINITIVE  REPORT  443 
demonstrated that mixtures of two such lymphocyte cell lines, which differ at 
the HL-A locus, are able to synthesize and secrete a cell-free soluble factor of 
35,000  daltons  which  can  nonspecifically increase  the  humoral  immune  re- 
sponse. Moreover, the activity of this HEF is effective, at least in vitro, across 
a  species-specific barrier, i.e., it is capable of amplifying the productive anti- 
body response of mouse B  cells to a  heterologous antigen. A factor of similar 
size and activity was specifically elicited from cultured normal human periph- 
eral blood leukocytes from a  tetanus  toxoid-primed donor when the priming 
antigen was added to the culture medium. 
In murine systems, specifically activated T lymphocytes have been shown to 
release soluble mediators which  influence the  humoral  immune  responses of 
syngeneic B  lymphocytes (6, 8). The murine enhancing factor previously de- 
scribed was a protein of 75,000 tool wt which was elicited in vitro in a manner 
similar to that shown for HEF, i.e., by antigenic or allogeneic stimulation of 
primed thymus-derived cells (8). In the case of HEF, it is not unlikely that the 
human lymphocyte class which is triggered to release the factor is also thymus 
derived. However, we have not as yet shown this to be so. The human and 
murine enhancing factors differ in molecular weight, and also in electrophoretic 
mobility in polyacrylamide gels. HEF is 35,000 daltons in tool wt and migrates 
during gel electrophoresis to the section marked B in Fig. 2, while murine EF 
is larger (75,000 daltons)  and has an electrophoretic mobility similar to that 
of the molecules in the band marked C  (8)3 Despite their differences in size 
and charge density, these mediators quite clearly have similar functional effects 
when added to mouse spleen cell cultures 48 h after the induction of an in vitro 
immune response to a particulate antigen. 
SUMMARy 
The mixing of two histoincompatible human lymphocyte cell lines generated 
the release of a  soluble factor which was capable of nonspecifically enhancing 
the  in  vitro  immune  response  of  normal  mouse  spleen  cells  against  sheep 
erythrocytes. When active supernates were subjected to exclusion chromatog- 
raphy on Sephadex G-150 and BioGel P-150, the active principle eluted with 
molecules of approximately 35,000  mol  wt.  Column  aliquots  from  similarly 
treated supernates from independent cultures of each lymphoid cell line were 
inactive. The human enhancing factor was concentrated and purified by am- 
monium  sulfate fractionation, followed by Sephadex gel filtration and poly- 
acrylamide gel electrophoresis. 
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